Eli Lilly Copy of $8 Billion Sanofi Insulin Wins EU Approval

30.06.2014 - The European Medicine Agency (EMA) has recommended approval of Abasria, Eli Lilly's biosimilar version of Sanofi's insulin glargine sold as Lantus. This means that the French...